ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2013

Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis.

Sophie Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.